SSH Notice - Holliday Group Holdings (ICT Investments) Ltd

Posted by Default Admin on 18 December 2014

DISCLOSURE OF MOVEMENT OF 1% OR MORE IN SUBSTANTIAL HOLDING OR CHANGE IN NATURE OF RELEVANT INTEREST OR BOTH

Sections 277 and 278, Financial Markets Conduct Act 2013

TO: NZX Limited  and  TO: Finzsoft Solutions Limited ("FIN")

Relevant event being disclosed: Change in nature of relevant interest  Date of relevant event: 18 December 2014  Date this disclosure made: 18 December 2014  Date last disclosure made: 21 November 2013  Substantial product holder(s) giving disclosure

Full name(s): Holliday Group Holdings (ICT Investments) Limited ("HGH")

Summary of substantial holding

Class of quoted voting products: Ordinary shares  Summary for: HGH  For this disclosure:  (a) total number held in class: 5,646,438  (b) total in class: 8,566,163  (c) total percentage held in class: 65.916%  For last disclosure:  (a) total number held in class: 5,646,438  (b) total in class: 8,314,000  (c) total percentage held in class: 67.915%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure: On 18 December 2014, HGH entered into a lock-up agreement with Silverlake HGH Limited in relation to a proposed full takeover offer for all of the equity securities of FIN. Under that agreement, Silverlake HGH Limited has agreed, subject to the provisions of the agreement, to make a full takeover offer for all of the equity securities in FIN, and HGH has agreed to accept that offer in respect of its holding of 5,646,438 shares in FIN.  Details after relevant event

Details for: HGH  Nature of relevant interest(s): Registered holder and beneficial owner of financial products subject to the lock-up agreement (attached as document A, 24 pages)  For that relevant interest:  (a) number held in class: 5,646,438  (b) percentage held in class: 65.916%  (c) current registered holder(s): HGH  (d) registered holder(s) once transfers are registered: Silverlake HGH Limited

Additional information

Address(es) of substantial product holder(s): 22 Winscombe Street, Belmont, Auckland, 0622  Contact details: Andrew Holliday  Phone: +64 21 355 492  Email: Andrew.Holliday@finzsoft.com  Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: Silverlake HGH Limited

Certification

I, Andrew Alexander Holliday, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

 Download PDF